Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis.

Sanchorawala, V; Wright, D G; Quillen, K; Finn, K T; Dember, L M; Berk, J L; Doros, G; Fisher, C; Skinner, M; Seldin, D C

Sanchorawala, V; Wright, D G; Quillen, K; Finn, K T; Dember, L M; Berk, J L; Doros, G; Fisher, C; Skinner, M; Seldin, D C.

Affiliation

Sanchorawala V; Department of Medicine [corrected] Stem Cell Transplantation Program, Section of Hematology-Oncology, Boston University School of Medicine [corrected] Boston, MA, USA. Vaishali.Sanchorawala@bmc.org

Bone Marrow Transplant ; 40(6): 557-62, 2007 Sep.

Article in En | MEDLINE | ID: mdl-17589534

Subject(s)

Amyloidosis/drug therapy; Antineoplastic Agents, Alkylating/administration & dosage; Hematopoietic Stem Cell Transplantation; Immunoglobulin Light Chains; Melphalan/administration & dosage; Adult; Aged; Amyloidosis/mortality; Amyloidosis/therapy; Antineoplastic Agents, Alkylating/adverse effects; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation/mortality; Humans; Male; Melphalan/adverse effects; Middle Aged; Patient Dropouts; Prospective Studies; Survival Rate; Transplantation, Autologous; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin Light Chains / Hematopoietic Stem Cell Transplantation / Antineoplastic Agents, Alkylating / Amyloidosis / Melphalan Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2007 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links